Eris partners with Pharmanutra S.P.A of Italy for Sideral
Eris partners with 3S Bio Group of China for TPIAO
Eris Lifesciences acquires trademark Zomelis from Novartis AG for India market
Eris Lifesciences Ltd (Eris) acquired the Indian branded formulations business of
UTH is largely engaged in the segments of Obesity, Diabetes, Gestational diabetes mellitus, Maternal nutrition, and Cardio-vascular diseases.
We have entered into a distribution agreement with India Medtronic Private Limited for the distribution, marketing and promotion
Eris acquires majority stake
Eris acquires trademarks in relation